Leading North American Biotech-Company Selects Comintell’s Competitive Intelligence Software Over Competition

OTTAWA--(BUSINESS WIRE)--Sept. 8, 2006--Comintell, the leading provider of competitive intelligence software, today announced that Theratechnologies (TSX:TH), a Canadian biopharmaceutical company, has selected and implemented Comintell Knowledge XChanger (KXC) to power their competitive intelligence system. Being a late-stage bio-tech company, the need for strategic intelligence is fundamental for Theratechnologies and they now have a tool that helps them identify growth opportunities and gives early warning of competitive threats.

MORE ON THIS TOPIC